Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XTR004 PET vs MIBI SPECT in borderline coronary stenosis
NCT07187895Phase 2Terminated
- Sponsor
- Sinotau Pharmaceutical Group
- Start
- Dec 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-FMPP, sponsored by Sinotau Pharmaceutical Group. Started Dec 2024; status: terminated.
02
Drugs
18F-FMPP
Beyond the preview
Go deeper on NCT07187895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07187895.